Novartis AG /
Chinook Therapeutics, Inc.
Novartis completes merger with Chinook Therapeutics, Inc.
What happened
Novartis AG completed its merger with Chinook Therapeutics, Inc. on August 11, 2023. Chinook became an indirect wholly owned subsidiary of Novartis.
Chinook stockholders became entitled to $40.00 in cash per share and one contractual contingent value right.
The source
Everything on this page comes from the source below.
Novartis completes merger with Chinook Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly